{
    "title": "110_hr5485",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``PEPFAR Accountability and \nTransparency Act''.\n\nSEC. 2. EVALUATION OF HIV/AIDS PROGRAMS.\n\n    Subtitle A of title III of the United States Leadership Against \nHIV/AIDS, Tuberculosis, and Malaria Act of 2003 (22 U.S.C. 7631 et \nseq.) is amended by adding at the end the following:\n\n``SEC. 308. PROGRAM MONITORING, OPERATIONS RESEARCH, AND IMPACT \n              EVALUATION RESEARCH.\n\n    ``(a) Program Established.--The Coordinator of United States \nGovernment Activities to Combat HIV/AIDS Globally (referred to in this \nsection as the `Coordinator') shall establish a mechanism to evaluate \nglobal HIV/AIDS programs financed by the United States Government in \norder to improve accountability, increase transparency, and ensure the \ndelivery of evidence-based services. Such mechanism shall include \nprogram monitoring, operations research, and impact evaluation \nresearch.\n    ``(b) Definitions.--In this subsection:\n            ``(1) Impact evaluation research.--The term `impact \n        evaluation research' means the application of research methods \n        and statistical analysis to measure the extent to which a \n        change in a population-based outcome can be attributed to \n        program intervention instead of other environmental factors.\n            ``(2) Operations research.--The term `operations research' \n        means the application of social science research methods and \n        statistical analysis to judge, compare, and improve policies \n        and program outcomes, from the earliest stages of defining and \n        designing programs through their development and \n        implementation.\n            ``(3) Program monitoring.--The term `program monitoring' \n        means the collection, analysis, and use of routine program data \n        to determine how well a program is carried out and how much the \n        program costs.\n            ``(4) Eligible entities.--The term `eligible entities' \n        means public or private organizations, including academic \n        institutions, that have documented experience in analyzing and \n        evaluating the effectiveness of health, development, or other \n        international aid programs.\n    ``(c) Use of Funds.--The Coordinator shall use amounts provided \nunder this section, either directly or indirectly through grants, \ncontracts, or cooperative agreements to eligible entities, to conduct \nprogram monitoring, operations research, and impact evaluation research \nrelated to programs authorized under this Act. Such activities shall be \nconducted to--\n            ``(1) improve the coverage, efficiency, effectiveness, \n        quality, and accessibility of services provided under this Act;\n            ``(2) establish the cost-effectiveness of program models;\n            ``(3) assess the population-level impact of programs \n        implemented, including the impact of programs on women, \n        children, and other at-risk or vulnerable populations;\n            ``(4) ensure the transparency and accountability of \n        services provided under this Act;\n            ``(5) disseminate and promote the utilization of evaluation \n        findings, lessons, and best practices in the implementation of \n        the programs receiving financial assistance under this Act;\n            ``(6) encourage and evaluate innovative service models and \n        strategies to optimize the delivery of care, treatment, and \n        prevention programs financed by the United States Government; \n        and\n            ``(7) strengthen ongoing program monitoring and enhance \n        program quality through routine program evaluations, such as \n        midterm and final program evaluations.\n    ``(d) Report.--Not later than 90 days after the date of the \nenactment of the PEPFAR Accountability and Transparency Act, the \nCoordinator shall submit a report to Congress that describes the \nresources provided under this Act for program monitoring, operations \nresearch, and impact evaluation research during the 5-year period \nending on September 30, 2008, that describes--\n            ``(1) the projects for which resources were obligated and \n        the outcomes of those projects;\n            ``(2) the program improvements, including cost or other \n        resource savings, which have been made as a result of program \n        monitoring, operations research, and impact evaluation \n        research;\n            ``(3) how program monitoring, operations research, and \n        impact evaluation research priorities are determined and how \n        input from external experts is incorporated; and\n            ``(4) the process used to allocate funding for \n        implementation of program monitoring, operations research, and \n        impact evaluation research.\n    ``(e) Strategic Plan.--\n            ``(1) In general.--Not later than 1 year after the date of \n        the enactment of the PEPFAR Accountability and Transparency \n        Act, the Coordinator shall develop a 5-year strategic plan for \n        program monitoring, operations research, and impact evaluation \n        research.\n            ``(2) Plan elements.--The plan developed under this \n        subsection shall include--\n                    ``(A) the amount of funding provided for program \n                monitoring, operations research, and impact evaluation \n                research under this Act available through fiscal year \n                2009;\n                    ``(B) strategies to address the goals described in \n                subsection (c);\n                    ``(C) priorities for program monitoring, operations \n                research, and impact evaluation research and a time \n                line for completion of activities associated with such \n                priorities; and\n                    ``(D) other information that the Coordinator \n                determines to be necessary.\n            ``(3) Considerations.--In developing the plan under this \n        subsection, the Coordinator shall consider a range of research \n        priorities, including research in--\n                    ``(A) preventing new HIV infections by reducing \n                behavioral risks for HIV transmission, particularly in \n                at-risk and vulnerable populations, including--\n                            ``(i) delaying sexual debut;\n                            ``(ii) reducing the number of sexual \n                        partners;\n                            ``(iii) practicing abstinence, fidelity, \n                        and monogamy;\n                            ``(iv) using condoms, other effective \n                        protection methods that have been developed and \n                        are available, and female condoms; and\n                            ``(v) meeting the needs of discordant \n                        couples;\n                    ``(B) improving health care delivery systems and \n                HIV/AIDS-related policies;\n                    ``(C) preventing mother-to-child transmission, \n                improving early identification of infected children, \n                and reducing the spread of HIV infections, particularly \n                in women and girls;\n                    ``(D) reducing HIV-related mortality and morbidity \n                of HIV;\n                    ``(E) treating adults and children infected by HIV \n                more effectively, including establishing better \n                approaches for increasing access to treatment and \n                increasing and sustaining treatment adherence;\n                    ``(F) addressing the vulnerabilities of married and \n                unmarried women and girls to HIV infection, including \n                those who are victims of rape, sexual violence, and \n                coercion;\n                    ``(G) integrating family planning into HIV/AIDS \n                prevention, care, and treatment strategies and \n                services;\n                    ``(H) encouraging men to be responsible for their \n                sexual behavior and to respect women, including the \n                reduction and elimination of sexual violence and \n                coercion;\n                    ``(I) developing models for scaling up HIV \n                counseling, testing with informed consent, and other \n                approaches that promote risk reduction and access to \n                care and treatment;\n                    ``(J) addressing risks associated with substance \n                use;\n                    ``(K) promoting the most effective models for \n                scaling up care and treatment access;\n                    ``(L) ensuring a safe blood supply;\n                    ``(M) improving injection safety, including \n                eliminating unnecessary injections and promoting \n                sterile injection practices and technologies;\n                    ``(N) improving health care workers' occupational \n                health and safety;\n                    ``(O) strengthening hospice and palliative care;\n                    ``(P) scaling up the provision of prevention, care \n                and treatment services to children, including those \n                orphaned by HIV/AIDS;\n                    ``(Q) preventing HIV through male circumcision; and\n                    ``(R) other research that the Coordinator \n                determines to be necessary.\n            ``(4) Consultation.--In developing the strategic plan and \n        implementing, disseminating, and promoting the use of program \n        monitoring, operations research, and impact evaluation \n        research, the Coordinator shall consult with representatives \n        of--\n                    ``(A) the National Institutes of Health;\n                    ``(B) the United States Agency for International \n                Development;\n                    ``(C) the Centers for Disease Control and \n                Prevention;\n                    ``(D) the Agency for Healthcare Research and \n                Quality;\n                    ``(E) the Department of Health and Human Services;\n                    ``(F) the Department of Labor;\n                    ``(G) other Federal agencies engaged in global HIV/\n                AIDS programs;\n                    ``(H) multilateral structures, such as the United \n                Nations and the Global Fund To Fight AIDS, Tuberculosis \n                and Malaria;\n                    ``(I) national governments of foreign countries in \n                which programs under this Act are administered;\n                    ``(J) organizations implementing programmatic \n                activities under this Act; and\n                    ``(K) other organizations with expertise in \n                monitoring and evaluating international HIV/AIDS \n                programs.\n            ``(5) Meeting and public comment.--The Coordinator shall--\n                    ``(A) not later than 180 days after the date of the \n                enactment of the PEPFAR Accountability and Transparency \n                Act, hold a public meeting at which the public may \n                present its views on the current needs and gaps in \n                program monitoring, operations research, and impact \n                evaluation research;\n                    ``(B) during the 30-day period following the public \n                meeting held pursuant to subparagraph (A), collect \n                written comments from the public; and\n                    ``(C) publish the comments received pursuant to \n                subparagraph (B) on the Office of the Global AIDS \n                Coordinator's Internet Web site.\n            ``(6) Review of strategic plan.--The Coordinator shall--\n                    ``(A) not later than 1 year after the date of the \n                enactment of the PEPFAR Accountability and Transparency \n                Act, present the strategic plan developed under this \n                subsection to the appropriate congressional committees;\n                    ``(B) publish the strategic plan in the Federal \n                Register and on the Office of the Global AIDS \n                Coordinator's Internet Web site;\n                    ``(C) during the 60-day period following the \n                publication of the plan under subparagraph (B), solicit \n                written comments on the plan from the public;\n                    ``(D) hold a meeting at which the public is given \n                an opportunity to present its views on the plan; and\n                    ``(E) after consideration of the views and comments \n                received from the public, make any necessary revisions \n                to the plan.\n    ``(f) Best Practices Report.--The Coordinator shall annually \npublish a best practices report that highlights the programs that have \nthe potential for translation, particularly at a low cost, across \nglobal AIDS programs, including those that focus on both generalized \nand localized epidemics, receiving financial assistance from the United \nStates.\n    ``(g) Dissemination of Findings.--\n            ``(1) In general.--The Coordinator shall disseminate the \n        full findings of the multiple operations research and impact \n        evaluation research and program level monitoring efforts on the \n        Office of the Global AIDS Coordinator's Internet website in \n        order to improve transparency and public availability of \n        information about operations research and impact evaluation \n        research.\n            ``(2) Dissemination guidance.--The Coordinator shall \n        develop guidance to ensure timely submission and dissemination \n        of all impact evaluation research, operations research, and \n        program monitoring findings. The time lines and processes \n        included in such guidance shall take into account the \n        publication process for peer-reviewed scientific or academic \n        journals and the discussion of such research findings at a \n        scientific meeting or any other public or private forum, so as \n        to maintain the scientific process without unduly restricting \n        dissemination of information.\n    ``(h) Authorization of Appropriations.--In addition to funds made \navailable under section 401(a), there are authorized to be appropriated \nsuch sums as may be necessary to carry out this section.''."
}